Sunshine Biopharma, Inc.
SBFM
Price:
$2.22
Market Cap:
$1.11M
Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, and liver cancers. Notably, Adva-27a also demonstrates efficacy against multidrug-resistant cancer cells, encompassing pancreatic, breast, small-cell lung, and uterine sarcoma cells. The company is also progressing SBFM-PL4, a compound under development as...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-02-15
Stock Exchange
NASDAQ
Ticker
SBFM
PE Ratio
[-0.18]
ROE
[-25.58%]
Current Ratio
[4.22]
Dividend Yield
[0%]
Enterprise Value
[-5056885.00]
Dividend History
The ROE as of June 2026 (TTM) for Sunshine Biopharma, Inc. (SBFM) is -25.58%
According to Sunshine Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -25.58%. This represents a change of 299.37% compared to the average of -6.40% of the last 4 quarters.
Sunshine Biopharma, Inc. (SBFM) Historical ROE (quarterly & annually)
How has SBFM ROE performed in the past?
The mean historical ROE of Sunshine Biopharma, Inc. over the last ten years is 16.53%. The current -25.58% ROE has changed -254.77% with respect to the historical average. Over the past ten years (40 quarters), SBFM's ROE was at its highest in in the December 2018 quarter at 607.42%. The ROE was at its lowest in in the September 2018 quarter at -2032.01%.
Average
16.53%
Median
80.09%
Minimum
-5875.62%
Maximum
3.87%
Sunshine Biopharma, Inc. (SBFM) ROE by Quarter and Year
Discovering the peaks and valleys of Sunshine Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.03%
Maximum Annual ROE = 3.87%
Minimum Annual Increase = -2115.11%
Minimum Annual ROE = -5875.62%
| Year | ROE | Change |
|---|---|---|
| 2025 | -25.94% | 18.72% |
| 2024 | -21.85% | 2.82% |
| 2023 | -21.25% | -82.82% |
| 2022 | -123.66% | -97.90% |
| 2021 | -5875.62% | -2115.11% |
| 2020 | 291.58% | 29.15% |
| 2019 | 225.77% | -94.16% |
| 2018 | 3.87% | 2.03% |
| 2017 | 181.43% | -89.12% |
| 2016 | 1.67% | 502.31% |
Sunshine Biopharma, Inc. (SBFM) Average ROE
How has SBFM ROE performed in the past?
The current ROE of Sunshine Biopharma, Inc. (SBFM) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-23.01%
5-year avg
-1213.66%
10-year avg
16.53%
Sunshine Biopharma, Inc. (SBFM) ROE vs. Peers
How is SBFM’s ROE compared to its peers?
Sunshine Biopharma, Inc.’s ROE is greater than Biofrontera Inc. (-476.72%), greater than cbdMD, Inc. (-33.59%), greater than Evoke Pharma, Inc. (-101.40%), greater than HCW Biologics Inc. (-102.39%), less than Inspira Technologies Oxy B.H.N. Ltd. (0%), less than Check-Cap Ltd. (416.71%), greater than Innovative Eyewear, Inc. (-83.38%), greater than Sonoma Pharmaceuticals, Inc. (-85.94%), less than Profusa, Inc. Common Stock (154.23%), greater than Acurx Pharmaceuticals, Inc. (-153.93%),
| Company | ROE | Market cap |
|---|---|---|
| -476.72% | $11.08M | |
| -33.59% | $7.20M | |
| -101.40% | $18.95M | |
| -102.39% | $2.67M | |
| 0% | $45.04M | |
| 416.71% | $10.88M | |
| -83.38% | $3.47M | |
| -85.94% | $1.89M | |
| 154.23% | $124.83K | |
| -153.93% | $2.49M |
Build a custom stock screener for Sunshine Biopharma, Inc. (SBFM) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sunshine Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Sunshine Biopharma, Inc. (SBFM) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Sunshine Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Sunshine Biopharma, Inc.'s ROE?
How is the ROE calculated for Sunshine Biopharma, Inc. (SBFM)?
What is the highest ROE for Sunshine Biopharma, Inc. (SBFM)?
What is the 3-year average ROE for Sunshine Biopharma, Inc. (SBFM)?
What is the 5-year average ROE for Sunshine Biopharma, Inc. (SBFM)?
How does the current ROE for Sunshine Biopharma, Inc. (SBFM) compare to its historical average?